These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 12974773

  • 1. Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity.
    Geijtenbeek TB, van Kooyk Y.
    APMIS; 2003; 111(7-8):698-714. PubMed ID: 12974773
    [Abstract] [Full Text] [Related]

  • 2. A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.
    van Kooyk Y, Appelmelk B, Geijtenbeek TB.
    Trends Mol Med; 2003 Apr; 9(4):153-9. PubMed ID: 12727141
    [Abstract] [Full Text] [Related]

  • 3. DC-SIGN: escape mechanism for pathogens.
    van Kooyk Y, Geijtenbeek TB.
    Nat Rev Immunol; 2003 Sep; 3(9):697-709. PubMed ID: 12949494
    [Abstract] [Full Text] [Related]

  • 4. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ, Koning N, Ambrosini M, Kalay H, Vuist I, Sarrami-Forooshani R, Geijtenbeek TB, van Kooyk Y.
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [Abstract] [Full Text] [Related]

  • 5. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells.
    Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y.
    J Immunol; 2003 Feb 15; 170(4):1635-9. PubMed ID: 12574325
    [Abstract] [Full Text] [Related]

  • 6. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation.
    Koppel EA, van Gisbergen KP, Geijtenbeek TB, van Kooyk Y.
    Cell Microbiol; 2005 Feb 15; 7(2):157-65. PubMed ID: 15659060
    [Abstract] [Full Text] [Related]

  • 7. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I, van Vliet SJ, Nyame AK, Cummings RD, Bank CM, Appelmelk B, Geijtenbeek TB, van Kooyk Y.
    Glycobiology; 2003 Jun 15; 13(6):471-8. PubMed ID: 12626400
    [Abstract] [Full Text] [Related]

  • 8. DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14.
    Koppel EA, Saeland E, de Cooker DJ, van Kooyk Y, Geijtenbeek TB.
    Immunobiology; 2005 Jun 15; 210(2-4):203-10. PubMed ID: 16164027
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.
    Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, van Duijnhoven GC, Kraal G, van Oosterhout AJ, van Kooyk Y.
    Blood; 2002 Oct 15; 100(8):2908-16. PubMed ID: 12351402
    [Abstract] [Full Text] [Related]

  • 12. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ.
    Clin Sci (Lond); 2003 Apr 15; 104(4):437-46. PubMed ID: 12653690
    [Abstract] [Full Text] [Related]

  • 13. Pathogen recognition by DC-SIGN shapes adaptive immunity.
    Geijtenbeek TB, den Dunnen J, Gringhuis SI.
    Future Microbiol; 2009 Sep 15; 4(7):879-90. PubMed ID: 19722841
    [Abstract] [Full Text] [Related]

  • 14. Innate signaling by the C-type lectin DC-SIGN dictates immune responses.
    den Dunnen J, Gringhuis SI, Geijtenbeek TB.
    Cancer Immunol Immunother; 2009 Jul 15; 58(7):1149-57. PubMed ID: 18998127
    [Abstract] [Full Text] [Related]

  • 15. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.
    Cardinaud S, Urrutia A, Rouers A, Coulon PG, Kervevan J, Richetta C, Bet A, Maze EA, Larsen M, Iglesias MC, Appay V, Graff-Dubois S, Moris A.
    Eur J Immunol; 2017 May 15; 47(5):818-829. PubMed ID: 28266028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissue.
    Canard B, Vachon H, Fontaine T, Pin JJ, Paul S, Genin C, Mueller CG.
    Immunol Lett; 2011 Mar 30; 135(1-2):165-72. PubMed ID: 21078343
    [Abstract] [Full Text] [Related]

  • 18. Mycobacteria target DC-SIGN to suppress dendritic cell function.
    Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, Van Kooyk Y.
    J Exp Med; 2003 Jan 06; 197(1):7-17. PubMed ID: 12515809
    [Abstract] [Full Text] [Related]

  • 19. Sugar and spice: viral envelope-DC-SIGN interactions in HIV pathogenesis.
    Su SV, Gurney KB, Lee B.
    Curr HIV Res; 2003 Jan 06; 1(1):87-99. PubMed ID: 15043214
    [Abstract] [Full Text] [Related]

  • 20. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.
    Immunol Lett; 2014 Jan 06; 158(1-2):33-41. PubMed ID: 24239607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.